Home Tcelltech

Tcelltech

In operation
-
Tumor Drug R&D and Production
Basic
Enterprise Profile

Basic Information

Tcelltech GmbH, a subsidiary of the German Cancer Research Center (DKFZ), has developed a universal personalized adoptive cell therapy for all cancers. The company's mission is to provide therapeutic benefits to the majority of cancer patients.
Tcelltech GmbH
Baden-Wurttemberg,Germany
unclear
January 01, 2022
info@tcelltech.de

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products Immune Cell Therapy
Concept
Tumor Therapeutic Products
Application Scenarios
Biologics Innovative Drugs